119 related articles for article (PubMed ID: 37086631)
21. Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles.
Huang Q; Li F; Liu L; Xu R; Yang T; Ma X; Zhang H; Zhou Y; Shao Y; Wang Q; Xi H; Ding Y
Front Pharmacol; 2023; 14():1302142. PubMed ID: 38035023
[No Abstract] [Full Text] [Related]
22. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
23. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
24. An
Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
[TBL] [Abstract][Full Text] [Related]
25. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
[TBL] [Abstract][Full Text] [Related]
26. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
[TBL] [Abstract][Full Text] [Related]
27. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
28. HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
Cui Y; Zhang C; Li Y; Ma S; Cao W; Guan F
Cell Biol Int; 2021 Jun; 45(6):1246-1259. PubMed ID: 33559901
[TBL] [Abstract][Full Text] [Related]
29. TIP-B1 promotes kidney clear cell carcinoma growth and metastasis via EGFR/AKT signaling.
Yin L; Gao S; Shi H; Wang K; Yang H; Peng B
Aging (Albany NY); 2019 Sep; 11(18):7914-7937. PubMed ID: 31562290
[TBL] [Abstract][Full Text] [Related]
30. HIG1 domain family member 1A is a crucial regulator of disorders associated with hypoxia.
Jia YZ; Liu J; Wang GQ; Pan H; Huang TZ; Liu R; Zhang Y
Mitochondrion; 2023 Mar; 69():171-182. PubMed ID: 36804467
[TBL] [Abstract][Full Text] [Related]
31. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
Front Immunol; 2022; 13():982045. PubMed ID: 36353618
[TBL] [Abstract][Full Text] [Related]
32. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
[TBL] [Abstract][Full Text] [Related]
33. Mining database and verification of PIK3CB as a marker predicting prognosis and immune infiltration in renal clear cell carcinoma.
Ye J; Zeng T
Medicine (Baltimore); 2022 Jun; 101(22):e29254. PubMed ID: 35665729
[TBL] [Abstract][Full Text] [Related]
34. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract][Full Text] [Related]
35. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
[TBL] [Abstract][Full Text] [Related]
36. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
[TBL] [Abstract][Full Text] [Related]
37. APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome.
Zeng W; Xiong G; Hua L; Hu Y; Guo X; Peng X
Sci Rep; 2022 Jul; 12(1):12406. PubMed ID: 35858961
[TBL] [Abstract][Full Text] [Related]
38. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
Xu L; He J; Cai Q; Li M; Pu X; Guo Y
Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X
J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033
[TBL] [Abstract][Full Text] [Related]
40. Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma.
Xiong W; Zhong J; Li Y; Li X; Wu L; Zhang L
J Immunol Res; 2022; 2022():2818777. PubMed ID: 35945960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
